Gyas Khan

591 total citations
44 papers, 399 citations indexed

About

Gyas Khan is a scholar working on Molecular Biology, Complementary and alternative medicine and Oncology. According to data from OpenAlex, Gyas Khan has authored 44 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Complementary and alternative medicine and 9 papers in Oncology. Recurrent topics in Gyas Khan's work include Medicinal Plants and Neuroprotection (5 papers), Natural Antidiabetic Agents Studies (5 papers) and Nigella sativa pharmacological applications (5 papers). Gyas Khan is often cited by papers focused on Medicinal Plants and Neuroprotection (5 papers), Natural Antidiabetic Agents Studies (5 papers) and Nigella sativa pharmacological applications (5 papers). Gyas Khan collaborates with scholars based in Saudi Arabia, India and China. Gyas Khan's co-authors include Tarique Anwer, Mohammad Firoz Alam, Mohammed M. Safhi, Rahimullah Siddiqui, Sivakumar S. Moni, Saeed Alshahrani, Syed Ehtaishamul Haque, Manju Sharma, Mohd Neyaz Ahsan and Sajid Ali and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Brain Research.

In The Last Decade

Gyas Khan

33 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gyas Khan Saudi Arabia 11 118 86 56 54 51 44 399
Rahimullah Siddiqui Saudi Arabia 13 95 0.8× 64 0.7× 25 0.4× 42 0.8× 99 1.9× 20 353
Maha A. Aldubayan Saudi Arabia 15 46 0.4× 140 1.6× 37 0.7× 49 0.9× 47 0.9× 60 620
Lohanathan Bharathi Priya Taiwan 15 109 0.9× 213 2.5× 83 1.5× 56 1.0× 63 1.2× 18 642
Jovana Bradić Serbia 15 62 0.5× 121 1.4× 47 0.8× 50 0.9× 28 0.5× 61 545
Vinod Kumar Nelson India 12 65 0.6× 156 1.8× 19 0.3× 38 0.7× 40 0.8× 39 453
Mehmet Cengiz Üstüner Türkiye 11 75 0.6× 84 1.0× 22 0.4× 22 0.4× 75 1.5× 20 364
Linda Chularojmontri Thailand 11 65 0.6× 142 1.7× 66 1.2× 38 0.7× 148 2.9× 26 478
Kesavarao Kumar Ebenezar India 10 138 1.2× 113 1.3× 51 0.9× 85 1.6× 34 0.7× 26 373
Hardik Gandhi India 10 83 0.7× 85 1.0× 72 1.3× 72 1.3× 31 0.6× 34 378
Kirtikar Shukla United States 16 59 0.5× 211 2.5× 49 0.9× 53 1.0× 32 0.6× 29 570

Countries citing papers authored by Gyas Khan

Since Specialization
Citations

This map shows the geographic impact of Gyas Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gyas Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gyas Khan more than expected).

Fields of papers citing papers by Gyas Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gyas Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gyas Khan. The network helps show where Gyas Khan may publish in the future.

Co-authorship network of co-authors of Gyas Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Gyas Khan. A scholar is included among the top collaborators of Gyas Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gyas Khan. Gyas Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hussain, Md Sadique, Ali Hanbashi, Gyas Khan, et al.. (2025). CRISPR-Edited Cell Lines: A New Era in Functional Oncology Research. Current Pharmaceutical Design. 32(13). 1027–1034.
2.
Maqbool, Mudasir, Gyas Khan, L. Zhang, & Md Sadique Hussain. (2025). Controversial Role of Opioids: From Pain Control to Cancer Recurrence in Breast Cancer. Current Cancer Drug Targets. 25(11). 1335–1348.
3.
Khan, Gyas & Md Sadique Hussain. (2025). Expanding the Potential of Gene Therapy for Duchenne Muscular Dystrophy. Current Pharmaceutical Design. 32(5). 330–337.
4.
5.
Abdullah, Muhammad Khalil, et al.. (2025). "Not So Reversible" a Case of Fatal Malignant Posterior Reversible Encephalopathy Syndrome in the Setting of End-stage Renal Disease. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1584–A1584.
6.
Ahmed, Mohammed Gulzar, et al.. (2025). Crocus sativus and Neurological Health: A Review on Depression and Impaired Neurogenesis. Current Pharmaceutical Design. 32(11). 854–868.
7.
Khan, Gyas, et al.. (2025). Ferroptosis and its contribution to cognitive impairment in Alzheimer’s disease: mechanisms and therapeutic potential. Brain Research. 1864. 149776–149776. 5 indexed citations
8.
Hussain, Md Sadique, Gyas Khan, & Gaurav Gupta. (2025). Advances in Gene Therapy for X-Linked Myotubular Myopathy: Current Progress and Future Challenges. Current Gene Therapy. 26(1). 9–10.
9.
Mishra, Arun Kumar, Amrita Mishra, Arvind Kumar, et al.. (2025). Role of dietary phytopharmaceuticals across the globe to alleviate the Alzheimer’s disease: mechanism-based approach. Phytomedicine Plus. 5(4). 100877–100877.
10.
11.
Mishra, Arun Kumar, et al.. (2024). Synthesis, characterization, computational studies and anti-inflammatory activity evaluation of some new indole substituted aryl ethers. Journal of Molecular Structure. 1322. 140290–140290.
12.
Almeleebia, Tahani M., Md Habban Akhter, Habibullah Khalilullah, et al.. (2024). Co-Delivery of Naringin and Ciprofloxacin by Oleic Acid Lipid Core Encapsulated in Carboxymethyl Chitosan/Alginate Nanoparticle Composite for Enhanced Antimicrobial Activity. ACS Omega. 9(6). 6845–6860. 8 indexed citations
13.
Kumar, Arvind, Vijay P. Singh, Arun Kumar Mishra, et al.. (2024). Synthesis, characterization and computational studies of some new vanillin derivatives for cosmetic purpose. Journal of Molecular Structure. 1327. 141127–141127. 1 indexed citations
14.
Gupta, Himanshu, Soniya Dhiman, Arvind Kumar, et al.. (2024). Photo- and Bio-degradation of Selected Persistent Organic Pollutants. Separation and Purification Reviews. 54(1). 3–16. 4 indexed citations
15.
Ullah, Shehla Nasar Mir Najib, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, et al.. (2023). Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art. Biomedicines. 11(6). 1752–1752. 38 indexed citations
16.
Khan, Gyas, Mohammad Firoz Alam, Saeed Alshahrani, et al.. (2023). Trastuzumab-Mediated Cardiotoxicity and Its Preventive Intervention by Zingerone through Antioxidant and Inflammatory Pathway in Rats. Journal of Personalized Medicine. 13(5). 750–750. 5 indexed citations
17.
Ullah, Shehla Nasar Mir Najib, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, et al.. (2023). Bedaquiline-Loaded Solid Lipid Nanoparticles Drug Delivery in the Management of Non-Small-Cell Lung Cancer (NSCLC). Pharmaceuticals. 16(9). 1309–1309. 4 indexed citations
18.
Alqahtani, Safar M., Ali Altharawi, Majed Alrobaian, et al.. (2023). UPLC–MS/MS Method Development for Simultaneous Estimation of Diclofenac and Resveratrol-Loaded Liposomal Gel Formulation in Mice Skin Model: Application to Dermatokinetic Study. Journal of Chromatographic Science. 61(4). 329–338. 2 indexed citations
19.
Alam, Mohammad Firoz, et al.. (2020). Zingerone ameliorates tellurium induced nephrotoxicity by abating elevated serum markers in the rats. SHILAP Revista de lepidopterología. 21(1&2). 125–129. 3 indexed citations
20.
Alam, Mohammad Firoz, Mohammed M. Safhi, Tarique Anwer, et al.. (2018). Therapeutic potential of Vanillylacetone against CCl4 induced hepatotoxicity by suppressing the serum marker, oxidative stress, inflammatory cytokines and apoptosis in Swiss albino mice. Experimental and Molecular Pathology. 105(1). 81–88. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rahimullah Siddiqui Breakdown of academic impact, for papers by Maha A. Aldubayan Breakdown of academic impact, for papers by Lohanathan Bharathi Priya Breakdown of academic impact, for papers by Jovana Bradić Breakdown of academic impact, for papers by Vinod Kumar Nelson Breakdown of academic impact, for papers by Mehmet Cengiz Üstüner Breakdown of academic impact, for papers by Linda Chularojmontri Breakdown of academic impact, for papers by Kesavarao Kumar Ebenezar Breakdown of academic impact, for papers by Hardik Gandhi Breakdown of academic impact, for papers by Kirtikar Shukla
Rankless by CCL
2026